Merdury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 5.10
-0.25 (-4.67%)
Sep 8, 2026, 1:40 PM CST
Merdury Biopharmaceutical Market Cap
Merdury Biopharmaceutical has a market cap or net worth of 2.42 billion as of September 8, 2026. Its market cap has decreased by -27.29% in one year.
Market Cap
2.42B
Enterprise Value
2.33B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.10
ChartMarket Cap Chart
Since December 23, 2022, Merdury Biopharmaceutical's market cap has decreased from 5.10B to 2.42B, a decrease of -52.49%. That is a compound annual growth rate of -18.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 2.42B | -30.18% |
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orient EuroPharma | 3.97B |
| Easywell Biomedicals | 3.73B |
| Yoda Pharmaceuticals | 3.68B |
| Tien Liang BioTech | 2.84B |
| Maywufa Company | 2.78B |
| Allied Biotech | 2.66B |
| PhytoHealth | 2.26B |
| Johnson Chemical Pharmaceutical Works | 2.26B |